These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15156311)

  • 1. [Treatment of osteoarthritis of the knee joint. Efficacy and tolerance to acemetacin slow release in comparison to celecoxib].
    Leeb BF; Bucsi L; Keszthelyi B; Böhmova J; Valesova M; Hawel R; Mayrhofer F; Singer F; Aglas F; Bröll H
    Orthopade; 2004 Sep; 33(9):1032-41. PubMed ID: 15156311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
    Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
    J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.
    Pincus T; Koch G; Lei H; Mangal B; Sokka T; Moskowitz R; Wolfe F; Gibofsky A; Simon L; Zlotnick S; Fort JG
    Ann Rheum Dis; 2004 Aug; 63(8):931-9. PubMed ID: 15082468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
    Emery P; Koncz T; Pan S; Lowry S
    Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
    Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A
    Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.
    Conaghan PG; Dickson J; Bolten W; Cevc G; Rother M
    Rheumatology (Oxford); 2013 Jul; 52(7):1303-12. PubMed ID: 23542612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee.
    Williams GW; Hubbard RC; Yu SS; Zhao W; Geis GS
    Clin Ther; 2001 Feb; 23(2):213-27. PubMed ID: 11293555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
    Rother M; Lavins BJ; Kneer W; Lehnhardt K; Seidel EJ; Mazgareanu S
    Ann Rheum Dis; 2007 Sep; 66(9):1178-83. PubMed ID: 17363401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee.
    Bianchi M; Broggini M
    Drugs; 2003; 63 Suppl 1():37-46. PubMed ID: 14506910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized, double blind, multicentre, parallel group study to compare efficacy and safety of acemetacin and indometacin in patients with activated osteoarthrosis of the knee].
    Gallacchi G; Hodinka L
    Praxis (Bern 1994); 2009 Jun; 98(12):635-42. PubMed ID: 19513973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
    Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
    Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
    Lehmann R; Brzosko M; Kopsa P; Nischik R; Kreisse A; Thurston H; Litschig S; Sloan VS
    Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
    J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis. A randomised, placebo, double-blind and cross-over trial.
    Detrembleur C; De Nayer J; van den Hecke A
    Osteoarthritis Cartilage; 2005 Mar; 13(3):206-10. PubMed ID: 15727886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
    Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
    Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial.
    Chopra A; Saluja M; Tillu G; Sarmukkaddam S; Venugopalan A; Narsimulu G; Handa R; Sumantran V; Raut A; Bichile L; Joshi K; Patwardhan B
    Rheumatology (Oxford); 2013 Aug; 52(8):1408-17. PubMed ID: 23365148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.